THE CYTOTOXIC EFFECT OF CHELIDONIUM MAJUS IN VITRO

Vladimíra Tomečková, Veronika Tkáčová, Peter Urban, Marek Stupák

Abstract


The effect of aqueous and ether Chelidonium majus haulms extract on cervical HeLa tumor cells, mammary adenocarcinoma MCF 7 tumor cells and acute lymphoblastic leukemia CEM tumor cells in vitro have been studied. The purpose of this research was to compare the effect of aqueous and ether Chelidonium majus haulms extract on selected tumor cells. Colorimetric MTT assay have been used for the study of the antiproliferative effect of aqueous and ether haulms extract of Chelidonium majus on cell viability in vitro. The results of the experiments have shown the cytotoxic effect of the aqueous and the ether Chelidonium majus haulms extract on the individual tumor cells. The aqueous Chelidonium majus haulms extract was the most effective on CEM cells, it was less effective on MCF 7 cells and it was the least effective on HeLa cells. The ether haulms extract of Chelidonium majus was the most effective at all of studied concentrations on CEM cells and MCF 7 cells in comparison with HeLa cells, where it was significantly effective only at the highest concentration. Aqueous and ether haulms extract of Chelidonium majus tested in vitro indicated their cytotoxic activity. Both haulms extract of Chelidonium majus were more efficient on CEM cells. It is assumed that higher antiproliferative activity of ether haulms extract of Chelidonium majus is the result of higher antiproliferative activity of lipophilic substances. The lipophilic substances pass through membrane and bind to various proteins and change their biological activity.

Keywords


cytotoxic effect, Chelidonium majus extract, MTT assay.

Full Text:

PDF

References


Bashmakova, N., Hovorun, D., Kutovyy. S., Losytskyy, M., Yashchuk, V., & Zaika, L. (2008). The DNA influence on spectral properties of the berberine, chelidonine and sanguinarine alkaloids. WDS´08 Proceedings of Contributed Papers, Part III, 163-167.

Biswas, S. J. (2013). Chelidonium majus L.  a review on pharmacological activities and clinical effects. Global Journal of Research on Medicinal Plants & Indigenous Medicine, 2, 238-245.

Boehm, K., & Edzard, E. (2013). Ukrain. CAM  Cancer Consortium [serial on the Internet]. Retrieved from http://cam-cancer.org/CAM-Summaries/Herbal-products/Ukrain.

Crijns, A. P., de Smet, P. A., van den Heuvel, M., Schot, B. W., & Haaqsma, E. B. (2002). Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus). Nederlands Tijdschrift voor Geneeskunde, 146, 100-102.

Dostal, J., & Potacek, M. (1990). Quaternary benzo[c]phenanthridine alkaloids. Collection of Czechoslovak Chemical Communications, 55, 2840-2873.

Dostal, J., & Slavik, J. (2000). Later knowledge about sanguinarine and related alkaloids. Chemistry Letters, 94,15-20.

European Medicines Agency (2011). Assesment report on Chelidonium majus L., herba. Retrieved from http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_HMPC_assessment_report

/2012/01/WC500120711.pdf

Ferrari, M., Fornasiero, M. C., & Isetta, A. M. (1990). MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. Journal of Immunological Methods, 131, 165-172.

Gausage, F., Ramadani, M., & Gausage, S. (2001). Cytotoxic effects of the alkaloid chelidonine from Chelidonium majus on pancreatic cancer cells. An old highly potent anticancer drug. Gastroenterology, 120, A617–A618.

Ishikawa, T. (2001). Benzo[c]phenanthridine bases and their antituberculosis activity. Medicinal Research Reviews, 21, 61-72.

Jiming, T., Yuling, L., Guanghui, C., Xigang, L., Siping, C., & Yanbin, M. (2001). A study on relieving cough and asthma effects of total alkaloid from Chelidonium majus. Journal of Chengde Medical College, 18, 277-279.

Lanvers-Kaminsky, C., Nolting, D. M., Koster, J., Schroder, A., Sandkotter, J,. & Boos, J. (2006). In-vitro toxicity of Ukrain against human Ewing tumor cell lines. Anticancer Drugs, 17, 1025-1030.

Malikova, J., Zdarilova, A., & Hlobilkova, A. (2006). Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomedical papers of the Medical Faculty of the University Palacký, 150, 1-5.

Minarik, J. (1979). Farmakognozie [Pharmacognosy] (1st ed.). Praha: Avicenum.

Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.

Motilal, M., & Gopinatha, S. K. (2007). Molecular aspects on the interaction of protoberberine, benzophenanthridine and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Medicinal Research Reviews, 27, 649-695.

Slavik, J. (1980). Alkaloidy čeledi mákovitých (Papaveraceae) [dissertation]. Brno: University of J. E. Purkyně.

Stickel, F., Poschl, G., Seitz, H. K., Waldherr, R., Hahn, E. G., & Schuppan, D. (2003). Acute hepatitis induced by greater celandine (Chelidonium majus). Scandinavian Journal of Gastroenterology, 38, 565-568.

Tomko, J. (1999). Farmakognózia [Pharmacognosy] (2nd Ed.). Martin: Osveta.

Ulrichova, J., Dvorak, Z., Vicar, J., Lata, J., Smrzová, J., Sedo, A., & Simánek, V. (2001). Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzo[c]phenanthridine alkaloids. Toxicology Letters,125,125-132.

Vavreckova, C., & Ulrichova, J. (1994). Biologická aktivita kvartérnych benzo[c]fenathridinových alkaloidů sanguinarínu a chelerytrínu [Biological activity of quaternary benzo[c]phenanthridine alkaloids – sanguinarine and chelerythrine]. Chemistry Letters, 88, 238-248.

Xia, X., Yan, J., Shen, Y., Tang, K., Yin, J., Zhang, Y., Yang, D., Liang, H., Ye, J., & Weng. J. (2001). Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS ONE, 6:e16556.




DOI: http://dx.doi.org/10.12955/emhpj.v8i2.668

Refbacks

  • There are currently no refbacks.


Print ISSN 1804-5804, Online ISSN 1804-9702

(c) 2018 CBU,o.p.s.